• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: SCHIZOPHRENIA

Improving QoL in patients with schizophrenia

December 5, 2018  

Canadian real-world study of aripiprazole LAI in schizophrenia

August 23, 2018  

Use of injectable antipsychotics in bipolar I disorder

June 29, 2018  

Sun avoidance – more harm than good?

December 16, 2016  

APA highlights: Treatment trials in psychiatry

June 22, 2016  

Quality of life in schizophrenia: the QUALIFY trial

October 14, 2015  

Beyond remission: redefining the goal of schizophrenia management

August 4, 2015  

Relapse prevention in first-episode schizophrenia: role of long-acting injectables

January 14, 2015  

Long-acting injectable aripiprazole approved in Canada

August 13, 2014  

APA 2014: New Research – Part 2

July 9, 2014  
1
2
3

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions